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Background
Fibrinogen supplementation in trauma has been sug-
gested in order to restore or improve haemostatic com-
petence; this could possibly reduce or replace the need
for transfusions in case of bleeding. Results from func-
tional haemostatic assays indicate that lowered clot
strength is associated with a risk for massive transfu-
sions [1]. The optimal fibrinogen concentration or indi-
cations for supplementation in trauma patients have not
been established [2].
Aim
To examine the in vitro effect of adding fibrinogen con-
centrate to whole blood from trauma patients by
Thrombelastography (TEG).
Methods
Eleven patients with severe injury admitted to a Danish
level 1 trauma centre were enrolled in the study. Inclu-
sion was based on: systolic pressure < 100 mmHg and/or
GCS ≤ 8 and/or substantial bleeding. Eight out of eleven
patients received a transfusion within 12h after hospital
admission. Mechanisms of injury included: road traffic
accidents, fall injuries, and stab- and gunshot wounds. A
citrated blood sample was obtained at admittance. TEG
analyses were performed using both citrated kaolin (CK)
and functional fibrinogen (FF). CK clot strength (maxi-
mum amplitude; MA) reflecting both the platelet and the
fibrinogen contribution were compared to that of FF,
which solely reflects fibrinogen contribution to clot
strength. Volumes of fibrinogen concentrate equivalent
to 6g*75kg
-1 were added to samples prior to TEG analy-
sis. p < 0.05 was considered significant.
Results
Fibrinogen concentrate increased the clot strength in
both CK and FF assays (Fig.1). CK MA increased by 8%
(p = 0.013) and FF MA by 44% (p =0 . 0 0 5 )a f t e ra d d i -
tion of fibrinogen concentrate.
Conclusions
In whole blood from trauma patients with severe injury,
fibrinogen concentrate administered in a dose equivalent
to 6g*75kg
-1 increased clot strength significantly. These
results indicate a possible pro-haemostatic effect of fibri-
nogen concentrate in severely injured trauma patients.
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